Search

Dr. Bearss Elected as Director!

Updated: Dec 10, 2020

Reglagene is delighted to announce that its shareholders elected David Bearss, PhD, as Director. Dr. Bearss is a drug development expert. He has led teams that discovered 15 cancer medicines for which Initial New Drug applications were filed at the FDA, leading to human clinical trials. Dr. Bearss is a successful bioentrepreneur with several exits. As founder and CEO of Tolero Pharmaceuticals, he led its acquisition by Sumitomo Dainippon in 2017 for $780M. Dr. Bearss's talents and contributions will accelerate Reglagene's timelines to advancing new cancer medicines into human clinical trials.


Recent Posts

See All

Reglagene Featured on KGUN News!

"That's what we want to do. That is the dream: to irreversibly cure people's cancer," said Richard Austin, the CEO and Co-Founder of Reglagene. Reglagene was featured on KGUN news today!

Reglagene Featured in the Arizona Daily Star!

Reglagene was featured in the Arizona Daily Star! Director of Biology Teri Suzuki and Business Development Manager Michael Abrahamson were interviewed. Click here to read the full article and intervie

OFFICE

1703 E Mabel St
Tucson, AZ 85721
USA

www.reglagene.com  |  https://www.linkedin.com/company/reglagene/ | ©2020 by Reglagene Holding, Inc.